ReviewBiotechnology journal2026
Engineering Design of Artificial Phase-Separating Proteins.
Review in Biotechnology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Phase-separating proteins are evolutionarily conserved biomolecules that orchestrate key cellular processes. Although the biophysical principles underlying liquid-liquid phase separation (LLPS)-including multivalent interactions, intrinsically disordered regions (IDRs), and the sticker-spacer framework-are now well established, translating these insights into actionable engineering guidelines remains open challenges. Here, we present a design-oriented synthesis for engineering artificial phase-separating proteins. Drawing on a curated dataset, we characterize the physicochemical patterns associated with LLPS behavior, we evaluate current computational predictors, revealing systematic blind spots in hydrophobicity-rich or modular repeat architectures. Building on these insights, we propose modular design heuristics that encompasses sequence-level composition and patterning, valency control via repeat architecture, and topological fusion strategies including terminal tags, telechelic constructs, and interleaved block architectures. These design levers are mapped onto applications such as protein purification, catalytic condensates, stimuli-responsive systems, and mechanically hydrogels and fibers. Finally, we present an integrated design-build-test-learn (DBTL) framework that bridges predictive modeling, experimental iteration, and functional validation. By treating phase separation as an engineerable rather than merely emergent property, this review offers both a conceptual map and a practical roadmap for the rational construction of artificial phase-separating proteins across biotechnological and biomedical contexts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.